These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12387773)
101. Giardia lamblia in adults: a case study. Coughlan LF J Am Acad Nurse Pract; 1999 Oct; 11(10):431-4. PubMed ID: 10690093 [No Abstract] [Full Text] [Related]
102. Preventive role of probiotic bacteria against gastrointestinal diseases in mice caused by Giardia lamblia. Al-Megrin WA; Mohamed SH; Saleh MM; Yehia HM Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33600560 [TBL] [Abstract][Full Text] [Related]
103. Giardiasis: an overview for the clinician. Raizman RE Am J Dig Dis; 1976 Dec; 21(12):1070-4. PubMed ID: 1015507 [TBL] [Abstract][Full Text] [Related]
104. Giardia lamblia infestation in 154 children. Kay R; Barnes GL; Townley RR Aust Paediatr J; 1977 Jun; 13(2):98-104. PubMed ID: 907577 [No Abstract] [Full Text] [Related]
105. An atypical urticaria case caused by Giardia intestinalis. Yildiz Ozkaya D; Kartal O; Kalkan F J Infect Dev Ctries; 2022 Nov; 16(11):1781-1783. PubMed ID: 36449653 [TBL] [Abstract][Full Text] [Related]
107. Quality of life and its association with irritable bowel syndrome and fatigue ten years after giardiasis. Litleskare S; Rortveit G; Eide GE; Emberland KE; Hanevik K; Langeland N; Wensaas KA Neurogastroenterol Motil; 2019 May; 31(5):e13559. PubMed ID: 30767352 [TBL] [Abstract][Full Text] [Related]
111. Intestinal pseudo-obstruction caused by Pessarelli T; Basilisco G; Spina L; Fraquelli M BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36323453 [TBL] [Abstract][Full Text] [Related]
112. Infectious diseases of refugees and immigrants: giardiasis (Giardia lamblia). Roberts A; Kemp C J Am Acad Nurse Pract; 2001 Dec; 13(12):532-3. PubMed ID: 11836827 [No Abstract] [Full Text] [Related]
113. Drug Resistance in the Microaerophilic Parasite Leitsch D Curr Trop Med Rep; 2015; 2(3):128-135. PubMed ID: 26258002 [TBL] [Abstract][Full Text] [Related]
114. Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy. Michaels SA; Hulverson MA; Whitman GR; Tran LT; Choi R; Fan E; McNamara CW; Love MS; Ojo KK Antimicrob Agents Chemother; 2022 Jul; 66(7):e0001722. PubMed ID: 35703552 [TBL] [Abstract][Full Text] [Related]
115. Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis. Argüello-García R; Leitsch D; Skinner-Adams T; Ortega-Pierres MG Adv Parasitol; 2020; 107():201-282. PubMed ID: 32122530 [TBL] [Abstract][Full Text] [Related]
116. The old and new therapeutic approaches to the treatment of giardiasis: where are we? Busatti HG; Santos JF; Gomes MA Biologics; 2009; 3():273-87. PubMed ID: 19707415 [TBL] [Abstract][Full Text] [Related]
117. Structure-based identification of a potential non-catalytic binding site for rational drug design in the fructose 1,6-biphosphate aldolase from Giardia lamblia. Méndez ST; Castillo-Villanueva A; Martínez-Mayorga K; Reyes-Vivas H; Oria-Hernández J Sci Rep; 2019 Aug; 9(1):11779. PubMed ID: 31409864 [TBL] [Abstract][Full Text] [Related]
118. Giardiasis: a diagnosis that should be considered regardless of the setting. Escobedo AA; Almirall P; Hanevik K; Cimerman S; Rodríguez-Morales AJ; Almanza C; Auza-Santivañez J Epidemiol Infect; 2018 Jul; 146(10):1216-1218. PubMed ID: 29886858 [TBL] [Abstract][Full Text] [Related]
119. Incidence, Management Experience and Characteristics of Patients with Giardiasis and Common Variable Immunodeficiency. Díaz-Alberola I; Gutiérrez-Bautista JF; Espuch-Oliver A; García-Aznar JM; Anderson P; Jiménez P; Hidalgo-Tenorio C; López-Nevot MÁ J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498582 [TBL] [Abstract][Full Text] [Related]